A major broker has given its take, $1.25 12 month target, with the key points:
- US progress pleasing
- Capital raising to provide headroom for growth
- New products to provide potential future upside
$1.25 is a 90% premium to the share price close yesterday.
Of course, brokers are not always correct, and, as always, do your own research, but its nice to hear in my opinion.